MXCT vs SO
MaxCyte Inc (MXCT) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
MXCT currently screens at market cap $124.3M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the MXCT and SO stock pages for the full models.
Not investment advice.